Uptake of F18-FDG by renal interstitial inflammatory cells
Sanchez-Alamo B, et al. Facing the challenge of drug-induced acute interstitial nephritis. Nephron 2023; 147:78–90. doi: 10.1159/000525561
Nussbaum EZ, Perazella MA. Diagnosing acute interstitial nephritis: Considerations for clinicians. Clin Kidney J 2019; 12:808–813. https://academic.oup.com/ckj/article/12/6/808/5531252
Moledina DG, et al. Identification and validation of urinary CXCL9 as a biomarker for diagnosis of acute interstitial nephritis. J Clin Invest 2024; 134:e180583. doi: 10.1172/JCI168950
Krishnan N, Perazella MA. The role of PET scanning in the evaluation of patients with kidney disease. Adv Chronic Kidney Dis 2017; 24:154–161. doi: 10.1053/j.ackd.2017.01.002
Weitzer F, et al. Diagnostic value of F-18 FDG PET/CT in fever or inflammation of unknown origin in a large single-center retrospective study. Sci Rep 2022; 12:1883. doi: 10.1038/s41598-022-05911-7
Ghodsi A, et al. PET/computed tomography transformation of oncology: Immunotherapy assessment. PET Clin 2024; 19:291–306. doi: 10.1016/j.cpet.2023.12.012
Awiwi MO, et al. Imaging features of immune checkpoint inhibitor-related nephritis with clinical correlation: A retrospective series of biopsy-proven cases. Eur Radiol 2023; 33:2227–2238. doi: 10.1007/s00330-022-09158-8
Gupta S, et al. F18-FDG PET imaging as a diagnostic tool for immune checkpoint inhibitor-associated acute kidney injury. J Clin Invest 2024; 134:e182275. doi: 10.1172/JCI182275
Gupta S, et al.; ICPi-AKI Consortium Investigators. Acute kidney injury in patients treated with immune checkpoint inhibitors. J Immunother Cancer 2021; 9:e003467. doi: 10.1136/jitc-2021-003467